focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
If Stupidity does have a wings, some of the UK BB posters will fly like a bird, then it may happened, that All of us become patient realizing that we have a peace All over the USA and UK. My advice if you are not patient then sell and go away. All right you does have a doubt about Mylan – Sir Hank Klakurka and the funds behind him, or in to the payment, the go To USA - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Then open the registrar and read; “Pittsburgh, PA; May 12, 2007 – Mylan Laboratories Inc. (NYSE: MYL) and Merck KGaA today announced the signing of a definitive agreement under which Mylan will acquire Merck’s generics business (“Merck Generics”) for EUR 4.9 billion ($6.7 billion) in an all-cash transaction. The combination of Mylan and Merck Generics will create a vertically and horizontally integrated generics and specialty pharmaceuticals leader with a diversified revenue base and a global footprint. On a pro forma basis, for calendar 2006, the combined company would have had revenues of approximately $4.2 billion, EBITDA of approximately $1.0 billion and approximately 10,000 employees, immediately making it among the top tier of global generic companies, with a significant presence in all of the top five global generics markets.” “In addition to retaining Hank Klakurka, currently President and CEO of Merck Generics, Mylan has executed long-term employment agreements with members of Merck Generics’ senior management team, ensuring that senior leadership remains intact. Mylan views the existing management and employees of Merck Generics as key to the success of the combined company.” “Hank Klakurka, President and CEO of Merck Generics, said: “My management team and I are extremely excited to be joining the Mylan team. We believe Mylan is the best possible acquirer for our company. The two businesses are an excellent fit in terms of geography and product mix, and together we can offer extremely attractive product baskets across our combined territories. Mylan has established itself as a leader in the U.S. in terms of quality, manufacturing excellence and customer service, and has demonstrated a strong commitment to its employees and the communities in which it operates. My team and I look forward to working with Mylan to build an undisputed world leader in quality generics.”” Leadership and scale in key global regions : The transaction creates critical mass by combining Mylan’s leading position in the U.S. with Merck Generics’ broad geographic mix, including leading positions in Australia, France, Japan, Portugal, Spain and the U.K. This global footprint creates substantial growth opportunities, and reduces the risks associated with over-reliance on any one region. Transaction Details Under terms of the transaction, which have been unanimously approved by Mylan’s Board of Directors, Mylan will acquire
This is a Bright Idea! We do not have to be worry too much because we are All ready In the stock. Then start all over again. All we know is to the fact and does; An up-front payment from the partner company; = $1,3m Milestone payments during clinical development; up to $5m - $1,3m paid in front. Royalties on sales; this is and depend on the capacity of Mylan industry. And will go like that first year about 70% because before they do make entire production for all warehouses and stores then the rest on regular basis. Let say, that MYLAN capacity be like $500m That means within first year they shall bring HML income like $35m, that why the pharmacy companies does grow rapidly at the beginning of any new drugs issued.
Hi Randy!!! Right now everyone does looking to this few words of the last RSN News, (“KMS continues to work towards the deadline of 14 July 2010, and we will report further on any progress which has been made on or around that date.”) but the truth is, that we do not see the contract entered by the parties. Based on the few words posted by RSN we may only speculate on the issue. Then try to reveres such situation and jump to HML shoes. Well They are the most interested with the payment, if the contract is not binding contract then we will see info that they are place a claim with the court and so, and so. If they are so patient, why we shall make any noise about it. This is a agreement done by them and if they are patient from my point of view, there be no needs for any rush. Let say the Mylan does not provide cash yet for KSM, ($5m it is not a big deal for them but they are agree to few millstone payments for a reason). If they does not pay, means they has a reason for it. This type of transaction is always complicated because KSM be the owner of ICVT, but payee Mylan. That means there be few more contracts needed, or by law on KSM they does solve such issue. The most important issue at present tension is to the fact, that HML does all requirement stated in the contract up to KSM satisfaction, so that only the time may disturb the payment, and this does not excluding court mater in the worst issue or as it may happened. Those word below are not my but officially approved by HML and does make sense. “As per its business model to develop potential drugs until such a stage when they can be out-licensed, HML has entered into several licensing agreements and collaborations with established companies in the healthcare space. These collaborations have increased the company’s experience and understanding of the clinical and commercial potential of ICVT. The structure of licensing agreements is in line with industry standards and typically comprises: a) An up-front payment from the partner company; b) Milestone payments during clinical development; and c) Royalties on sales.”
Not exactly, first of all Merceler Teva and Mylan are in some fishy business, it looks like they sold nothing for something to TEVA but according to my knowledge these guys from Israel before they spend single penny, they do looks on both sides of the coin, on the other hand The Germans does not sell The Goose That Laid the Golden Eggs , but our interest stay with HML, and all of these issue are important for the future of HML. There be huge profit on IPR because all these fact mention above
Take a look !!!!! Mr. Hank Klakurka, Chief Executive Officer, Merck Generics Group, is pleased to announce the promotion of Martin A. Marino, LL.B. to the position of General Counsel, Merck Generics Group. As General Counsel, Mr. Marino assumes responsibility for the legal affairs of the Merck Generics Group on a global basis, and will report directly to Mr. Klakurka of Darmstadt, Germany. Mr. Marino has over 25 years of experience in corporate legal roles and executive management functions, with particular emphasis in transaction-based activities related to domestic and international corporate development. He also brings to the position considerable experience in conflict resolution and litigation management. Most recently, Mr. Marino served as Vice-President, Legal at Genpharm Inc. He will continue to be located at the Genpharm corporate office in Toronto.
Well going after Sir Hank Klakurka I did found such info. “Mylan Labs (MYL) sgrees to acquire generics ops of Merck KGaA for €4.9 billion ($6.7 billion) in cash. The company will retain Merck Generics' Presidenmt and CEO Hank Klakurka; it has executed long-term employment agreements with other members of Generics' senior management.” There after I got to that page “can you take calcium with diltiazem - KSM Band 19 Jun 2010 ... mylan diltiazem er 180 mg problems teva diltiazem cd ... apo diltiazem recall bakris gl: effects of diltiazem or lisinopril on massive proteinuria ... Hello, you need to enable JavaScript to use KSM Band. ... www.ksmofficial.com/forum/topics/can-you-take-calcium-with - ” So there after I got stock maybe someone be more clever to view it. This post has been made yesterday after suggestion to review MYLAN.
Hi Bigwil7 !!!!!! I thought that you are going to bring some argument today, but you do not. Well then listen to my. The IPR purchased by KSM itself does not bring anything to the buyer until The KSM be in position of massive production to use the IPR.. Thereafter If the product be ready, they need to sell the product so they need a system of distribution for the product and surgeon who will prescribe such treatment as contra-viral therapy. KSM of Poland and Germany does exist so the rest of the Europe is cover as well by Ratiopharm. If we await until such system be build by KSM with Hank Klakurka based on his statement with last LOI, That means He be in needs of Billions and not 5 millions. The reality does show for us that TEVA be the one who does it.
Hi Bigwil7 !!!!!! I’m very sorry to interrupt you again. I double thought what you does mention before as well. Permira is only interactive body. They do right contact for right reason. Hank Klakurka and the other members of the KSM Board are Canadians, Permira probably grand them trust in re to these activity and does provide the financial connection on which Klakurka does state in the last LOI. But positive he act independent in both VEM and TEVA interest based only on selling MG to Mylan. The web site I did mention does revel more such guys like Klakurka and shows in that topic right connection. So if all these guys work together when necessary there be huge possibility that that the second partner for LOI be the TEVA upon VEM approval.
Well I do not want to await any of your answer, Look to that. KSM was furious upon info posted by HML on 08,10,2009, and decide to act quickly, so we got, what we see, but as HML pointed they got something additional on KSM not only non biding contract if so?, this is TEVA or in both cases with KSM or additionaly. Last info posted by RSN show it clearly. (“Whilst we remain confident that negotiations with KMS will be concluded, we remain in discussions with the unnamed non European company that signed an LOI as announced on 8 October 2009, and we will continue these discussions until such time as the sale of ICVT is concluded.”) So basically case taking the may be two sales?
Hi Randy!!! Not like that, at 16,28 they shown 41,828, but as you see today is small plus. The LSEx on recounting this morning reflect – 12.90% so if we have now 3.23 means that + 12.9 = 16,13% on plus just today. The question is as to the fact of the “+”, are the HML put some money on the account as they do state in last RSN info or someone buy out of LSEx. Hi Bigwil7, at last someone with wish to show the difference. There be much more than that, go to this web page; http://www.terrapinn.com/2008/genericsusa/data/brochureeur8.pdf. Mr. Hank Klakurka, Chief Executive Officer, Merck Generics Holding GmbH Hank Klakurka has been involved in the pharmaceutical business for nearly 30 years. His career includes progressively more responsible positions, covering Sales, Marketing, Manufacturing and General Management, with high quality global pharmaceutical companies including Johnson & Johnson, Schering-Plough and Astra during this time. His Generic Pharma experience started in 1997 with the privately held global Generics Company Apotex Inc. He joined the Merck Group in 2001 as the Head of Genpharm in Canada and was responsible for Merck’s generics businesses in the America’s region. In January 2004, he was appointed as Chief Executive Officer of the Merck Generics Group, located in Darmstadt Germany. He graduated in Science from the University of Toronto in 1972 and he is married with two children.
Is KSM therapeutic the satellite of Ratiopharm? Yes the same Ratiopharm I did mention On Merckele auction. This part or how Ratiopharm has been sold, we all ready know, so today further action done. One of the Merckele family approved the idea on HML and the action with kingpin Hank Klakurka and since October were on. But on November Adolf Merckele got stock on VW shares, and bring huge loses for his VEM. This moment on the entire deal with HML got to nowhere. So on December They decide to sell Ratiopharm and once again Kingpin Hank Klakurka play major rules. The TEVA at this time buy the Ratiopharm. [The press info posted] “ratiopharm, founded by Adolf Merckle, is Germany's second largest generics producer and the sixth largest generic drug company worldwide. The Merckle family, through its investment vehicle VEM Vermoegensverwaltung GmbH, is selling the company. According to reports, Teva beat Iceland's Actavis Group as well as U.S. pharmaceuticals company Pfizer Inc. ( PFE | PowerRating) to win the battle for ratiopharm, which is being sold due to the huge debts collected by Adolf Merckle, who committed suicide early last year after losing millions of euros in soured stock market bets.” Then on March they make the deal and on March after approval by TEVA the deal move on HML. [go to this page http://www.rttnews.com/Content/BreakingNews.aspx?Id=1244950&pageNum=1&SimRec=2 ] Because Teva both one package Ratiopharm with KSM.
Yeah, you are right, some of the stock holder can sell ,and the capitalization go below 2,1m but this means that the one who sell is not an investor but on seaside mission. The only person with knowledge or brain until now in my opinion is the guy named Confidentholder because he does invest and do not panic. First of all we must consider two facts, are the HML provide the truth or not. If not then we may report with proper department, and the government go against these privet property so we shall receive back our investment. And because of that there be no needs to be worry this issue is out of question and no needs to pay more attention to it. All they say is true and on that bases we may consider the future, any suspect or empty words must be on ignore until some prove be provided.
Hi Randy/Biffus !!! What's the name of the game where you have see some strange action. Do you believe yesterday just before closing on LSEx I do invest additional money on HML, because the anticipated action on Monday morning. I did buy, but they reflect sale and only about 10 % of the investment I did. It happened at 16.28. Any way if you guys go through the last posted info by RSN in re HML, we have two important information; 1. – “The Company had available cash and bank facilities of circa £100,000 at 30 June 2010,” 2. – “It is currently expected that the financing arrangement will involve the issue of a convertible loan” The first information does provide for us perfect knowledge on our investment and the second does allowed for us to be patient until the payment from KSM does arrive. – WHY? – it is as simple as 2 +2 = 4. From the firs information we be able to figure what is the bottom for HML share. Let say that on the 30,06 the capital for HML was equal 2.3 m so after the necessary payment the bottom for HML be approximately 2,1m capitalization. Below that capitalization they has to sell partly the company equipment to lower the capitalization and we may anticipate that they does not do so, and the LSEx price on HML cannot or shall not go below ,15 (except some movement before final calculation on recounting be done), and this is the bottom. So furthermore from ,15 can only go up, up, up. If someone like me does purchase at ,16 do not have be worry about any losses below ,15. The price can move up and down upon the HML needs and current condition, but this is what investment is about, we give them cash and they does use it until they bring profit for our satisfaction. From the second info, we know that if any cash be needed by HML to complete the deal both Andrew Knight, and Chief Executive Dr Ian Pardoe will provide loan. Tomorrow, I will try to inform you what happened on the deal since November and why all of these delays.
Hi Randy !!!! Well All the communist countries are almost the same. If you want to buy something it is OK, but when you are in the country with investment those people are out of these mind. They do believe that they has a right to yours property and since you does not share with them they simply report you with the local government. And since they put these hands on you do not wait pack yours staffs and live. In those counties there is no justice system at all. All depend who you know, and if don’t the judgment be politically or economically motivated. In re to HML it is a form of game, they want some of these investor to fed up.
Well if you see such situation as drop Or rise without Any Shares deal done, then first of all, l do check capitalization on LSEx. If there is not any movement as well, that means only out of LSEx action (someone sell some stock). In re to the update of the letter of intent HML did the KSM deal payment [“In order to ensure the Company has adequate financial resources through the period to anticipated legal completion”]on 12 of July in the amount of or about 250K. So today some of the guys get fed up and sold, because time is money.
Hi Biffus / Randy !!!! The math sample apply to shoppers, and last week it is more likely quiet, but they does use it.
Hi Biffus / Randy !!!! You both right, time is money, well when I did my first steps in USA I did learn it, but there after I thought that Eastern Europe be the right place to move, and that was not the first mistake I did. There is math sample how to collect others people money, and as long you be in intention to reinvest such money it is OK, but if you mean consumption then in my opinion it is not right, do not consider expenses. For now I do try to restore myself and this is the reason why I do stick to HML.
This is what I do name protection against Panic – right knowledge – But If they know what we know they will not even bother to watch HML, in state of getting nap like me. This is what team is about if one of us watch only one stock, there always be more time for café. We can tell them one and important thing, The entire idea apply to German National interest and HML as private entity are allowed in at, based on these science knowledge. The contract specified term for now is one year, and thereafter if someone has a wish may get worry.
For now there is no much to be worry some wise guys got the idea to bet shorts, by the source of investment it looks like the trying to measure the intention
Good question; Why I do believe that Merkeler is behind Klakurka? This info were posted by unhappy investor (a millionaires as privet fund) “It has also been reported that BNP Paribas (Major Bank of Poland) and Commerzbank (Major Bank of Germany), the German bank running the sale on behalf of VEM Vermoegensverwaltung, the investment arm of the Merckle family, have agreed to make loans available to private-equity bidders in the auction. By committing to provide debt before a deal is agreed, this move is likely to have the effect of driving up the price and encouraging more competition among bidders” What it is about? The real intention were upon agreement of the German Government and Ratiopharm that they cannot agree to the right price of sale. So They got an idea that they will call all interested privet fund to auction and that way they get the highest and reasonable price on the deal. Even this was not the intention but happened that incidentally they make huge fun from all the millionaires. And there after situation were very similar to HML current position, that the Ratiopharm were very patient in re to the cash arrival.